diazooxonorleucine has been researched along with Cerebral Malaria in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hammoud, DA; Maric, D; Miller, LH; Munasinghe, JP; Pierce, SK; Powell, JD; Prchalova, E; Riggle, BA; Schreiber-Stainthorp, W; Sinharay, S; Slusher, BS | 1 |
Akkaya, M; Gordon, EB; Hamilton, SE; Hart, GT; Kim, AS; Lee, CF; Lo, YC; Miller, LH; Pena, M; Pierce, SK; Powell, JD; Qi, CF; Tran, TM; Waisberg, M; Yazew, T | 1 |
Crunkhorn, S | 1 |
3 other study(ies) available for diazooxonorleucine and Cerebral Malaria
Article | Year |
---|---|
MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice.
Topics: Adult; Animals; Antimalarials; Biomarkers; Blood-Brain Barrier; Brain; Brain Edema; Child; Diazooxonorleucine; Disease Models, Animal; Disease Progression; Female; Glutamine; Humans; Magnetic Resonance Imaging; Malaria, Cerebral; Malaria, Falciparum; Mice; Mice, Inbred C57BL; Plasmodium falciparum | 2018 |
Targeting glutamine metabolism rescues mice from late-stage cerebral malaria.
Topics: Animals; Antimalarials; Blood-Brain Barrier; Diazooxonorleucine; Glutamine; Malaria, Cerebral; Malaria, Falciparum; Mice | 2015 |
Infectious disease: Glutamine analogue reverses cerebral malaria.
Topics: Animals; Antimalarials; Diazooxonorleucine; Glutamine; Malaria, Cerebral; Malaria, Falciparum | 2015 |